Financing, Equity Capital Markets

Madrigal Pharmaceuticals, Inc.

03/24
|
$600.0 Million
Madrigal Pharmaceuticals, Inc.
Piper Sandler served as bookrunner for Madrigal Pharmaceuticals, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sub-Sector
Biopharma